Back to search
Idiopathic Multicentric Castleman's Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Idiopathic Multicentric Castleman's Disease trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Idiopathic Multicentric Castleman's Disease trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to understand the impact of sirolimus on idiopathic multicentric Castleman disease.
This study is a single-arm, open-label, multicenter, dose-escalation clinical study. Its primary purpose is to evaluate the safety and tolerability of recombina…